Effectiveness of oral budesonide suspension in adult patients with eosinophilic esophagitis

被引:0
|
作者
Karnam, Umaprasanna
Hirano, Ikuo
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A289 / A289
页数:1
相关论文
共 50 条
  • [31] TREATMENT WITH COMPOUNDED ORAL VISCOUS BUDESONIDE IS EFFECTIVE AND PROVIDES A DURABLE RESPONSE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
    Reed, Craig C.
    Fan, Claire
    Koutlas, Nathaniel T.
    Stefanidis, Zoe S.
    Eluri, Swathi
    Shaheen, Nicholas J.
    Dellon, Evan S.
    GASTROENTEROLOGY, 2017, 152 (05) : S864 - S865
  • [32] Evaluation of the Response to Oral Budesonide by the New Histology Scoring System Developed for Eosinophilic Esophagitis Patients
    Dinarvand, Peyman
    Eigbire-molen, Odianosen
    Guzman, Miguel
    Carpenter, Danielle
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1732 - 1733
  • [33] Efficacy And Safety Of Budesonide Oral Suspension In A Pediatric Population: Pooled Data From A Phase 2 And Phase 3 Trial In Patients With Eosinophilic Esophagitis
    Gupta, Sandeep
    Mukkada, Vincent
    Dellon, Evan
    Gold, Benjamin
    Collins, Margaret
    Katzka, David
    Falk, Gary
    Lan, Lan
    Desai, Nirav
    Williams, James
    Hirano, Ikuo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB91 - AB91
  • [34] TIME TO FIRST DYSPHAGIA SYMPTOM RESPONSE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION
    Dellon, Evan S.
    Collins, Margaret H.
    Katzka, David A.
    Mukkada, Vincent A.
    Falk, Gary W.
    Goodwin, Bridgett
    Wojtowicz, Abigail M.
    Boules, Mena
    Zhang, Wenwen
    Desai, Nirav K.
    Hirano, Ikuo
    GASTROENTEROLOGY, 2021, 160 (06) : S249 - S250
  • [35] TREATMENT OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS WITH OR WITHOUT CONCOMITANT THERAPIES: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION
    Hirano, Ikuo
    Katzka, David A.
    Collins, Margaret H.
    Wojtowicz, Abigail M.
    Zhang, Wenwen
    Boules, Mena
    Desai, Nirav K.
    Dellon, Evan S.
    GASTROENTEROLOGY, 2021, 160 (06) : S250 - S250
  • [36] Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial (vol 20, pg 525, 2022)
    Liu, Wanqing
    Chen, Peng
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (10) : 2418 - 2418
  • [37] DUPILUMAB NORMALIZES THE EOSINOPHILIC ESOPHAGITIS DISEASE TRANSCRIPTOME IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
    Hamilton, Jennifer D.
    Lim, Wei Keat
    Hamon, Sara C.
    Rothenberg, Marc E.
    Collins, Margaret H.
    Chehade, Mirna
    Harel, Sivan
    Wipperman, Matthew F.
    Hirano, Ikuo
    Dellon, Evan S.
    Brian, William
    Mannent, Leda
    Graham, Neil M.
    Patel, Naimish
    Ruddy, Marcella
    Radin, Allen
    GASTROENTEROLOGY, 2020, 158 (06) : S835 - S835
  • [38] Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis
    Fable, Jacqueline M.
    Fernandez, Marina
    Goodine, Susan
    Lerer, Trudy
    Sayej, Wael N.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (01): : 26 - 32
  • [39] Fluticasone Multidose Inhaler and Oral Viscous Budesonide Slurry in the Management of Eosinophilic Esophagitis
    Chan, Andrew T.
    Williams, Christopher S.
    GASTROENTEROLOGY, 2019, 157 (01) : 1 - 1
  • [40] PREDICTORS OF RESPONSE TO CORTICOSTEROID THERAPY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION
    Hirano, Ikuo
    Katzka, David A.
    Collins, Margaret H.
    Mukkada, Vincent A.
    Gold, Benjamin D.
    Falk, Gary W.
    Williams, James
    Desai, Nirav K.
    Lan, Lan
    Dellon, Evan S.
    GASTROENTEROLOGY, 2020, 158 (06) : S817 - S818